Nature Reviews Cancer

Papers
(The H4-Index of Nature Reviews Cancer is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Computing brain metastasis impact1718
Digging for treasures in the tumour interactome1239
An inhospitable site643
Combining spatial transcriptomics and AI to enhance brain tumour diagnosis595
Fructose takes a detour to feed cancer594
Implementing practice-changing progress for managing cancer of unknown primary402
Oncofetal reprogramming in tumour development and progression398
INVADEseq to study the intratumoural microbiota at host single-cell resolution388
Combinatorial strategies to target RAS-driven cancers384
Exploiting metabolic cell death for cancer therapy371
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment342
Emerging strategies to investigate the biology of early cancer341
How medical anthropology can contribute to cancer research335
Mapping the prostate cell family tree328
Fighting cancer with fat305
Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’294
3D chromatin architecture as a predictor of somatic mutations in cancer genomes272
Author Correction: Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma257
Connie J. Eaves (1944–2024)247
Antihistamines boost immunotherapy230
The recruitment of metastasis-associated monocytes224
The evolution of cancer and ageing: a history of constraint221
Tertiary lymphoid structures as hubs of antitumour immunity221
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies214
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel213
Translating premalignant biology to accelerate non-small-cell lung cancer interception211
Epithelial and stromal co-evolution and complicity in pancreatic cancer210
Context-dependent functions of pattern recognition receptors in cancer209
Nanoreceptors take down mutant p53193
No mutation, tumour initiation193
Gut microbes produce novel genotoxic metabolites193
Impersonating neurons192
Dendritic cells rise and shine184
Tumour EVPs disrupt liver function178
AACR 2025169
Measuring HLA disruption using MHC Hammer167
Persistence is key166
Thelpers? More like Ttroublemakers161
Removing barriers to address sex differences in anticancer drug toxicity161
Defining a ‘cells to society’ research framework for appendiceal tumours158
Moonlighting functions of glucose metabolic enzymes and metabolites in cancer151
Remodelling of the tumour microenvironment by the kallikrein-related peptidases148
3D bioprinted cancer models: from basic biology to drug development140
Natural killer cells in antitumour adoptive cell immunotherapy139
Bone voyage: immune crosstalk sets sail135
How chemokines organize the tumour microenvironment135
B-ring sterols to the rescue129
In-depth organoid profiling of pancreatic cancer127
Visualizing intratumoural heterogeneity with EpicMIBI126
The immune microenvironment of colorectal cancer123
Un-Fair Skin: racial disparities in acral melanoma research123
Identifying spatial cellular structures with SPACE-GM122
Points of entry for tumour-infiltrating lymphocytes121
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer121
Regulatory T cells in the tumour microenvironment118
Leveraging the replication stress response to optimize cancer therapy117
Linking cell mechanical memory and cancer metastasis115
The path to leptomeningeal metastasis113
Dynamics and specificities of T cells in cancer immunotherapy110
In situ decellularization of tissues to resolve the tumour-associated matrix104
Metabolic interplays between the tumour and the host shape the tumour macroenvironment104
Encoding spatial tumour dynamics with Starfysh101
Understanding and addressing race disparities in childhood cancer outcomes101
Race influences the tumour microbiome99
Deciphering the cancer genome and epigenome95
The link between vitamin D and prostate cancer92
Don’t blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic89
Polygenic scores in cancer86
ER stress sparks nerve pain85
Acetyl-CoA metabolism in cancer84
Cancer nanomedicine83
Targeted protein degradation for cancer therapy82
RNA splicing dysregulation and the hallmarks of cancer79
Z-nucleic acids give immunotherapy a boost77
Local CAR manufacturing76
0.13354301452637